ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 0271

External Validation of the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI) as a Predictor of Mortality and Organ Damage Accrual in Systemic Lupus Erythematosus

Alicia Malone1, Alexandra Legge1 and John Hanly1, 1Dalhousie University, Halifax, NS, Canada

Meeting: ACR Convergence 2020

Keywords: Damage Index, Mortality, Outcome measures, prognostic factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Friday, November 6, 2020

Session Title: SLE – Diagnosis, Manifestations, & Outcomes Poster I: Clinical Manifestations

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Using data from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort, a frailty index (FI) was recently developed as a measure of susceptibility to adverse health outcomes among individuals with SLE. In this work, higher baseline SLICC-FI values were associated with increased organ damage accrual and mortality risk during follow-up. While promising, these results require external validation. The objective of the current study was to evaluate the properties of the SLICC-FI in a prevalent cohort of individuals with more longstanding SLE.

Methods: This was a secondary analysis of data from a prospective cohort of adult SLE patients at a single academic medical center. All participants met the 1997 revised ACR classification criteria for SLE and were assessed annually for medication use, comorbidities, disease activity (SLEDAI-2K), organ damage [SLICC/ACR Damage Index (SDI)], health-related quality of life [Short-Form 36 (SF-36)], and other measures.

For this analysis, we defined the baseline visit as the first visit at which both SDI and SF-36 data were available. We created an adapted version of the original SLICC-FI by modifying the definitions of individual health deficits based on data availability. Using 48 health deficits, we calculated a baseline SLICC-FI score for each patient. Vital status and SDI score at last follow-up were recorded.

Cox regression was used to estimate the association between baseline SLICC-FI values and mortality risk. Negative binomial regression was used to estimate the association of baseline SLICC-FI values with the rate of change in SDI scores per patient-year of follow-up. Multivariable models adjusted for relevant baseline variables.

Results: The 329 eligible SLE patients (96% of cohort) were mostly female (88%) with mean (SD) age 43.9 (14.4) years and median (IQR) disease duration 3.4 (1.2-13.3) years at baseline. Mean (SD) baseline SLICC-FI score was 0.17 (0.08), with 94 patients (28.6%) classified as frail (SLICC-FI > 0.21).

Forty deaths occurred during mean (SD) follow-up of 10 (5.5) years. Mortality risk was significantly higher among frail individuals (Figure 1). Higher baseline SLICC-FI values (per 0.05 units) were associated with increased mortality risk (Hazard Ratio 1.42; 95% CI 1.14-1.78), after adjusting for age, sex, education, SLE medication use, disease duration, smoking status, and baseline SDI (Table 1).

There were 133 patients with an increase in SDI score during follow-up. Higher baseline SLICC-FI values (per 0.05 units) were associated with increased damage accrual over time (Incidence Rate Ratio 1.19; 95% CI 1.09-1.31), after adjusting for age, sex, corticosteroid use, disease duration, smoking status, and baseline SDI (Table 2).

These associations between baseline SLICC-FI values and adverse health outcomes persisted when inception patients (disease duration < 15 months at enrolment) were excluded, and when items related to organ damage were omitted from the SLICC-FI.

Conclusion: Frailty, measured using the SLICC-FI, predicts organ damage accrual and mortality risk among individuals with established SLE. This external validation study provides additional support for the SLICC-FI as a useful prognostic tool in SLE.


Disclosure: A. Malone, None; A. Legge, None; J. Hanly, None.

To cite this abstract in AMA style:

Malone A, Legge A, Hanly J. External Validation of the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI) as a Predictor of Mortality and Organ Damage Accrual in Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/external-validation-of-the-systemic-lupus-international-collaborating-clinics-frailty-index-slicc-fi-as-a-predictor-of-mortality-and-organ-damage-accrual-in-systemic-lupus-erythematosus/. Accessed January 17, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/external-validation-of-the-systemic-lupus-international-collaborating-clinics-frailty-index-slicc-fi-as-a-predictor-of-mortality-and-organ-damage-accrual-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.